tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:PRTC Stock Latest News

PureTech Health to Highlight Strategy at Leerink Global Healthcare Conference
Company AnnouncementsPureTech Health to Highlight Strategy at Leerink Global Healthcare Conference
18h ago
PureTech Health announces orphan drug designation for Deupirfenidone in IPF
PremiumThe Fly
PureTech Health announces orphan drug designation for Deupirfenidone in IPF
6d ago
PRTC
PureTech’s Deupirfenidone Wins U.S. and EU Orphan Status for Idiopathic Pulmonary Fibrosis
PremiumCompany Announcements
PureTech’s Deupirfenidone Wins U.S. and EU Orphan Status for Idiopathic Pulmonary Fibrosis
6d ago
PureTech CEO to Present at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
PureTech CEO to Present at J.P. Morgan Healthcare Conference
2M ago
PureTech Health appoints Robert Lyne as CEO
PremiumThe Fly
PureTech Health appoints Robert Lyne as CEO
2M ago
PRTC
PureTech Health Appoints Robert Lyne as CEO, Focuses on Strategic Growth
PremiumCompany AnnouncementsPureTech Health Appoints Robert Lyne as CEO, Focuses on Strategic Growth
2M ago
PureTech Health Addresses Shareholder Concerns Post-AGM
Premium
Company Announcements
PureTech Health Addresses Shareholder Concerns Post-AGM
3M ago
PureTech Health completes LYT-100 End-of-Phase 2 meeting with FDA
Premium
The Fly
PureTech Health completes LYT-100 End-of-Phase 2 meeting with FDA
3M ago
PRTC
PureTech Health Advances Deupirfenidone for IPF with FDA Support
PremiumCompany Announcements
PureTech Health Advances Deupirfenidone for IPF with FDA Support
3M ago
PureTech’s Gallop Oncology Reports Positive Phase 1b Trial Results for LYT-200 in AML
PremiumCompany Announcements
PureTech’s Gallop Oncology Reports Positive Phase 1b Trial Results for LYT-200 in AML
3M ago
PureTech’s Gallop Oncology Reports Promising Results for LYT-200 in AML Trial
PremiumCompany Announcements
PureTech’s Gallop Oncology Reports Promising Results for LYT-200 in AML Trial
4M ago
PureTech Health presents new analyses from ELEVATE IPF trial
PremiumThe Fly
PureTech Health presents new analyses from ELEVATE IPF trial
4M ago
PRTC
PureTech Health’s Deupirfenidone Shows Promise in Treating Older IPF Patients
PremiumCompany AnnouncementsPureTech Health’s Deupirfenidone Shows Promise in Treating Older IPF Patients
4M ago
PureTech Health’s Deupirfenidone Shows Promise in IPF Treatment
Premium
Company Announcements
PureTech Health’s Deupirfenidone Shows Promise in IPF Treatment
5M ago
PureTech Health Executives Increase Shareholdings, Indicating Confidence in Future Prospects
Premium
Company Announcements
PureTech Health Executives Increase Shareholdings, Indicating Confidence in Future Prospects
5M ago
PureTech Health says Seaport Therapeutics doses first patient in GlyphAgo study
PremiumThe Fly
PureTech Health says Seaport Therapeutics doses first patient in GlyphAgo study
6M ago
PRTC
Seaport Therapeutics Advances GlyphAgo for Generalized Anxiety Disorder
PremiumCompany Announcements
Seaport Therapeutics Advances GlyphAgo for Generalized Anxiety Disorder
6M ago
Buy Rating for PureTech Health Driven by Promising LYT-100 Developments and Strategic Initiatives
PremiumRatings
Buy Rating for PureTech Health Driven by Promising LYT-100 Developments and Strategic Initiatives
6M ago
PRTC
PureTech Health Discloses August 2025 Share Capital and Voting Rights
PremiumCompany Announcements
PureTech Health Discloses August 2025 Share Capital and Voting Rights
6M ago
PureTech Health’s Earnings Call: Cautious Optimism Amidst Changes
PremiumCompany AnnouncementsPureTech Health’s Earnings Call: Cautious Optimism Amidst Changes
6M ago
PureTech Health Advances Portfolio with Strong Financial Position
Premium
Company Announcements
PureTech Health Advances Portfolio with Strong Financial Position
6M ago
PureTech Health Advances Deupirfenidone in IPF Treatment
Premium
Company Announcements
PureTech Health Advances Deupirfenidone in IPF Treatment
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >